clinical trial · NCT06660342
A Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
Erosive EsophagitisHeartburnSymptomatic Non-erosive Gastroesophageal Reflux DiseaseHelicobacter Pylori InfectionVonoprazan
brief summary
The main objective of the study is to compare the maternal, fetal, and infant outcomes of pregnant women who are exposed to vonoprazan during pregnancy with outcomes of an internal comparison cohort of pregnant women who are unexposed to vonoprazan during pregnancy but who may be exposed to other products for the treatment of conditions for which vonoprazan may be prescribed.
started
May 15, 2025
primary completion
Sep 1, 2034
completion
Sep 1, 2034
last updated
May 22, 2025
official title
Vonoprazan Pregnancy Registry: An Observational Study of the Safety of Vonoprazan Exposure in Pregnant Women and Their Offspring
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol